Both in Biotechnology
Allogene Therapeutics vs C4 Therapeutics
Over the past year ALLO returned −8.1% and CCCC returned +32.1%; their daily moves had a correlation of 0.28.
ALLO −8.1% CCCC +32.1%Growth of $1, one year, split-adjusted
| Metric | ALLO | CCCC |
|---|---|---|
| Price | $1.09 | $3.28 |
| Market cap | $374.9M | $402.9M |
| Today | −8.05% | −2.82% |
| 1 month | −27.7% | +11.0% |
| 6 months | −52.0% | +7.9% |
| Year to date | −20.8% | +71.5% |
| 1 year | −10.3% | +33.1% |
| Revenue growth (YoY) | — | +2.8% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −919.8% | −355.9% |
| P/E (TTM) | — | — |
| Price / sales | 80.8× | 11.5× |
| Net cash | $332.6M | $253.7M |
| Dividend yield | — | — |
| Volatility (60d) | 55.2% | 65.1% |
| Short % of float | 19.4% | 43.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).